Discrimination between ribonuclease H- and ribonuclease L-mediated RNA degradation by 2′-O-methylated 2-5A-antisense oligonucleotides

This publication has 19 references indexed in Scilit:

• 2′,5′-Oligoadenylate-Antisense Chimeras Cause RNase L to Selectively Degrade bcr/abl mRNA in Chronic Myelogenous Leukemia Cells
  Blood, 1998
• Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA
  Oncogene, 1998
• The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation
  Pharmacology & Therapeutics, 1998
• Molecular Mechanisms of Antisense Drugs: RNase H
  Antisense and Nucleic Acid Drug Development, 1998
• Assessment of High-Affinity Hybridization, RNase H Cleavage, and Covalent Linkage in Translation Arrest by Antisense Oligonucleotides
  Antisense and Nucleic Acid Drug Development, 1998
• Antisense oligonucleotides: Is the glass half full or half empty?
  Biochemical Pharmacology, 1998
• Background of the Antisense Oligonucleotide Approach to Chemotherapy
  Antisense and Nucleic Acid Drug Development, 1997
• Detection of Ribonuclease H-Generated mRNA Fragments in Human Leukemia Cells Following Reversible Membrane Permeabilization in the Presence of Antisense Oligodeoxynucleotides
  Antisense Research and Development, 1995
• Blockage of NF-κB Signaling by Selective Ablation of an mRNA target by 2-5A Antisense Chimeras
  Science, 1994
• 2',5'-Oligoadenylate:antisense chimeras. Synthesis and properties
  Bioconjugate Chemistry, 1993